Geistlich Pharma Ag
Clinical trials sponsored by Geistlich Pharma Ag, explained in plain language.
-
New hope for tough pancreatic cancer? early trial combines GP-2250 with chemo
Disease control OngoingThis early-phase study tests a new drug called GP-2250 combined with the chemotherapy gemcitabine in people with advanced pancreatic cancer that has not responded to previous treatment. The main goal is to find a safe dose and check for side effects. About 64 adults with this typ…
Phase: PHASE1 • Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New bone graft material aims to improve spine fusion success
Disease control OngoingThis study tests whether Orthoss®, a bone graft extender, is safe and effective for spine fusion surgery in adults with lower back problems like slipped vertebrae or spinal stenosis. 65 participants received the material during surgery to help bones fuse together. The main goal i…
Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated May 22, 2026 13:52 UTC